Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Hematology/Oncology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin. 2018; 68: 394-424
- Cancer statistics, 2018.CA Cancer J Clin. 2018; 68: 7-30
- Endometrial cancer.Lancet. 2016; 387: 1094-1108
- Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.Gynecol Oncol. 2015; 136: 3-7
- ACOG committee opinion no. 557: management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women.Obstet Gynecol. 2013; 121: 891-896
- Revised FIGO staging for carcinoma of the endometrium.Int J Gynaecol Obstet. 2009; 105: 109
- Corpus uteri.in: Stephen E. Byrd D. Compton C. AJCC cancer staging handbook. 7 edition. Springer-Verlag, New York2010: 718
- A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.Lancet Oncol. 2017; 18: 384-392
- Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations.Gynecol Oncol. 2017; 146: 405-415
- Robotic-assisted vs traditional laparoscopic surgery for endometrial cancer: a randomized controlled trial.Am J Obstet Gynecol. 2016; 215: 588.e1-7
- Effect of total laparoscopic hysterectomy vs total abdominal hysterectomy on disease-free survival among women with stage I Endometrial Cancer: A Randomized Clinical Trial Laparoscopic vs Abdominal Hysterectomy for Stage I Endometrial Cancer Laparoscopic vs Abdominal Hysterectomy for Stage I Endometrial Cancer.JAMA. 2017; 317: 1224-1233
- Uterine neoplasms, version 1.2018, NCCN clinical practice guidelines in oncology.J Natl Compr Canc Netw. 2018; 16: 170-199
- 1A randomized phase III trial of pelvic radiation therapy (PXRT) versus vaginal cuff brachytherapy followed by paclitaxel/carboplatin chemotherapy (VCB/C) in patients with high risk (HR), early stage endometrial cancer (EC): A Gynecologic Oncology Group trial.Gynecol Oncol. 2014; 134: 438
- Phase III Trial: adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel/carboplatin in high-intermediate and high-risk early stage endometrial cancer.J Clin Oncol. 2019; 37: 1810-1818
- Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.Lancet Oncol. 2018; 19: 295-309
- Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial.Lancet Oncol. 2016; 17: 1114-1126
- A randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel vs. carboplatin and paclitaxel for optimally debulked, advanced endometrial carcinoma.J Clin Oncol. 2017; 35: 5505
- Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer.N Engl J Med. 2019; 380: 2317-2326
- Association of chemotherapy and radiotherapy sequence with overall survival in locoregionally advanced endometrial cancer.Gynecol Oncol. 2019; 153: 41-48
- Cervical cancer.Lancet. 2019; 393: 169-182
- Cancer of the cervix uteri.Int J Gynaecol Obstet. 2018; 143: 22-36
- Magnetic resonance imaging for detection of parametrial invasion in cervical cancer: An updated systematic review and meta-analysis of the literature between 2012 and 2016.Eur Radiol. 2018; 28: 530-541
- Identification of distant metastatic disease in uterine cervical and endometrial cancers with FDG PET/CT: analysis from the ACRIN 6671/GOG 0233 multicenter trial.Radiology. 2018; 287: 176-184
- Cervical cancer, version 3.2019, NCCN clinical practice guidelines in oncology.J Natl Compr Canc Netw. 2019; 17: 64-84
- Minimally invasive versus abdominal radical hysterectomy for cervical cancer.N Engl J Med. 2018; 379: 1895-1904
- Survival after minimally invasive radical hysterectomy for early-stage cervical cancer.N Engl J Med. 2018; 379: 1905-1914
- FDA approves pembrolizumab for advanced cervical cancer with disease progression during or after chemotherapy.(Available at:)
- Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: results from the phase II KEYNOTE-158 study.J Clin Oncol. 2019; 37: 1470-1478
- An open-label, multicohort, phase I/II study of nivolumab in patients with virus-associated tumors (CheckMate 358): Efficacy and safety in recurrent or metastatic (R/M) cervical, vaginal, and vulvar cancers.J Clin Oncol. 2017; 35: 5504
- Circulating human papillomavirus DNA as a biomarker of response in patients with locally advanced cervical cancer treated with definitive chemoradiation.JCO Precis Oncol. 2018; : 1-8
- Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium.Int J Gynaecol Obstet. 2009; 105: 103-104
- Vulvar cancer, version 1.2017, NCCN clinical practice guidelines in oncology.J Natl Compr Canc Netw. 2017; 15: 92-120
- Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I.Gynecol Oncol. 2016; 140: 8-14
- Adjuvant radiation therapy for margin-positive vulvar squamous cell carcinoma: defining the ideal dose-response using the national cancer data base.Int J Radiat Oncol Biol Phys. 2017; 97: 107-117
- Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins.J Cancer Res Clin Oncol. 2016; 142: 489-495
- Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial.Obstet Gynecol. 2009; 114: 537-546
- The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma.Gynecol Oncol. 2006; 103: 1095-1099
- Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study.Int J Radiat Oncol Biol Phys. 2000; 48: 1007-1013
- A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study.Gynecol Oncol. 2012; 124: 529-533
- Concurrent radiation therapy and chemotherapy in the treatment of primary squamous cell carcinoma of the vulva.Cancer. 1995; 75: 2289-2294
- Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva.Gynecol Oncol. 1992; 47: 14-20
- Vulvar cancer treatment (PDQ(R)): health professional version. PDQ cancer information summaries.National Cancer Institute (US), Bethesda (MD)2019
- Gynecologic Oncology Group risk groups for vulvar carcinoma: improvement in survival in the modern era.Gynecol Oncol. 2007; 106: 521-525
- Prognostic importance of human papillomavirus (HPV) and p16 positivity in squamous cell carcinoma of the vulva treated with radiotherapy.Gynecol Oncol. 2016; 142: 293-298
- An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations.Gynecol Oncol. 2017; 146: 3-10
- Complications of pelvic radiation in patients treated for gynecologic malignancies.Cancer. 2014; 120: 3870-3883
- Appropriate magnetic resonance imaging techniques for gross tumor volume delineation in external beam radiation therapy of locally advanced cervical cancer.Oncotarget. 2018; 9: 10100-10109
- Dosimetric predictors of duodenal toxicity after intensity modulated radiation therapy for treatment of the para-aortic nodes in gynecologic cancer.Int J Radiat Oncol Biol Phys. 2014; 88: 357-362
- Consensus recommendations for radiation therapy contouring and treatment of vulvar carcinoma.Int J Radiat Oncol Biol Phys. 2016; 95: 1191-1200
- Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer.Int J Radiat Oncol Biol Phys. 2013; 86: 83-90
- Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG oncology-RTOG 1203.J Clin Oncol. 2018; 36: 2538-2544
- Intensity modulated radiation therapy for squamous cell carcinoma of the vulva: Treatment technique and outcomes.Adv Radiat Oncol. 2017; 2: 148-158
- Management of nodal disease in advanced cervical cancer.Semin Radiat Oncol. 2019; 29: 158-165
- Simultaneous integrated boost (SIB) of the parametrium and cervix in radiotherapy for uterine cervical carcinoma: a dosimetric study using a new alternative approach.Br J Radiol. 2016; 89: 20160526
- Simultaneous integrated boost (SIB) for treatment of gynecologic carcinoma: Intensity-modulated radiation therapy (IMRT) vs volumetric-modulated arc therapy (VMAT) radiotherapy.Med Dosim. 2017; 42: 230-237
- Methods, safety, and early clinical outcomes of dose escalation using simultaneous integrated and sequential boosts in patients with locally advanced gynecologic malignancies.Gynecol Oncol. 2014; 135: 239-243
- Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS).Brachytherapy. 2019; 18: 123-132
- American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles.Brachytherapy. 2012; 11: 33-46
- Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study.Radiother Oncol. 2016; 120: 434-440
- Prospective clinical implementation of a novel magnetic resonance tracking device for real-time brachytherapy catheter positioning.Int J Radiat Oncol Biol Phys. 2017; 99: 618-626
- A dosage system for use in the treatment of cancer of the uterine cervix.Br J Radiol. 1938; 11: 809-824
- Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy.Radiother Oncol. 2012; 103: 113-122
- Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study.Radiother Oncol. 2016; 120: 428-433
- Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study.Radiother Oncol. 2016; 120: 412-419
- National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements.Int J Radiat Oncol Biol Phys. 2014; 90: 1083-1090
- Disparities in standard of care treatment and associated survival decrement in patients with locally advanced cervical cancer.Gynecol Oncol. 2016; 143: 319-325
Article info
Footnotes
Disclosure: G. Suneja is supported by grants K08CA228631 and P30AI064518 from the US National Institutes of Health. A. Viswanathan receives textbook royalties from Spring and is the National Cancer Institute Uterine Task Force Chair.
Identification
Copyright
© 2019 Elsevier Inc. All rights reserved.
